SCHEMBL19862870

SCHEMBL19862870

c1ccc(-n2c3ccccc3c3c4oc5ccccc5c4cc(-c4ccc5oc6ccccc6c5c4)c32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.38
TSHR P16473 1/20 0.38
BRCA1 P38398 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ALOX5 P09917 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PPARG P37231 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594158 0.95 PLA2G2A (0.35) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL19862871 0.92 KDM4E (0.41) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL19863089 0.91 KDM4E (0.40) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL18594106 0.91 ALOX5 (0.36) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL19862844 0.91 ALOX5 (0.32) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL19862861 0.90 KDM4E (0.41) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL24609269 0.89 KDM4E (0.40) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL18594157 0.89 KDM4E (0.38) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL18594291 0.89 KDM4E (0.38) ALDH1A1MEN1KMT2APOLBTSHR
SCHEMBL18594161 0.88 SIRT2 (0.33) ALDH1A1MEN1KMT2APOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 ALDH1A1 242/4885MEN1 798/4885KMT2A 177/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 ALDH1A1 242/4885MEN1 798/4885KMT2A 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.